Application
Sample (30 ug of whole cell lysate) A: MCF-7 15% SDS PAGE diluted at 1:1000| Product Name | Midkine antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to Midkine (midkine (neurite growth-promoting factor 2))Midkine is a retinoic acid-responsive, heparin-binding growth factor expressed in various cell types during embryogenesis. It promotes angiogenesis, cell growth, and cell migration. Midkine is also expressed in several carcinomas, suggesting that it may play a role in tumorigenesis, perhaps through its effects on angiogenesis (summary by Reynolds et al., 2004 [PubMed 15197188]).[supplied by OMIM] |
| Immunogen | Full length human Midkine Recombinant protein. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| *Optimal dilutions/concentrations should be determined by the researcher.
: |
|
| Species Reactivity | Human |
| Predicted Reactivity | Pig, Rabbit, BovinePig (83%), Rabbit (83%), Bovine (83%) |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | FLJ27379 antibody MK antibody NEGF2 antibody MDK antibody midgestation and kidney protein antibody ARAP antibody neurite outgrowth-promoting factor 2 antibody neurite outgrowth-promoting protein antibody amphiregulin-associated protein antibody mi |
|---|---|
| Molecular Weight(MW) | 16 kDa (note) (6) |
| Cellular Localization | Secreted |
Application
Sample (30 ug of whole cell lysate) A: MCF-7 15% SDS PAGE diluted at 1:1000| Positive Control | NT2D1 , U87-MG , MCF-7 |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher.
: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
